
Latest Headlines
Top Stories
Breaking News
Stock Alerts
Wallstreet Events
Industry News
Industry News
Corp. Calendars
Stock Splits
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Cov Initiations
Cov. Reiterated
Economic News
Economic Calendar
Economic Scorecard
Cryptocurrency
Cryptocurrency
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
White House
General News
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Coronavirus
COVID-19 Calendar
Diet & Fitness
Kids Health
Men’s Health
Women’s Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Classic Rock
Rap/Hip-Hop
Alternative
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Intelligent Investor
Biotech Investor NEW
Latest News Videos
Free Content
Press Releases
Latest Headlines
Stock Alerts
Top Stories
Breaking News
Wallstreet Events
Industry News
Corp. Calendars
Stock Splits
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Cov Initiations
Cov. Reiterated
Economic Calendar
Economic Scorecard
Cryptocurrency
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
White House
General News
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Kids Health
Men’s Health
Women’s Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Classic Rock
Rap/Hip-Hop
Alternative
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Intelligent Investor
Biotech Investor
Latest News Videos
Free Content
Press Releases
Quick Facts
Bayer Returns To Q2 Profit, Sales Edge Up; Confirms Outlook
By RTTNews Staff Writer โ
| Published: 8/4/2026 2:20 AM ET
Addas your preferred news source on Google
German pharmaceutical and biotechnology company Bayer AG (BYR.L) returned to profit in the second quarter, primarily helped bysignificantly lower other operating expenses.
Net income attributable to Bayer stockholders was โฌ219 million, or โฌ0.23 per share, compared with a loss of โฌ199 million, or โฌ0.20 per share, a year earlier.
Other operating expenses declined sharply to โฌ569 million from โฌ2.111 billion a year earlier.
Excluding one-time items, core net income from continuing operations, however, decreased toโฌ934 million or โฌ0.95 per share from โฌ1.122 billion or โฌ1.14 per share a year earlier.
EBIT surged to โฌ827 million from โฌ13 million last year.
EBIT before special items was โฌ999 million, 0.5% up from โฌ994 million in the prior year.
EBITDA rose to โฌ1.985 billion from โฌ285 million a year ago, while EBITDA before special items increased 1.9% to โฌ2.144 billion from โฌ2.105 billion.
Net sales edged up 1.2% to โฌ10.872 billion from โฌ10.739 billion in the prior-year quarter.
By segment, Crop Science sales increased to โฌ4.910 billion from โฌ4.788 billion a year earlier, driven by a 2.6% increase in volume and a 0.9% improvement in pricing.
Pharmaceuticals sales were broadly unchanged from the prior-year quarter, as strong growth from Nubeqa, Kerendia and the Radiology business largely offset declines in Eylea and Xarelto following patent expirations.
Consumer Health posted slightly higher sales, supported by growth across most product categories, led by Digestive Health, which was partly offset by weaker Allergy & Cold sales.
Looking ahead, Bayer reaffirmed its currency-adjusted 2026 guidance, continuing to expect sales of โฌ45 billion to โฌ47 billion, representing flat to 3% growth year over year. Core earnings per share is still expected at โฌ4.30 to โฌ4.80.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Next Story
Latest Updates on Middle East War
U.S. Dollar Ticked Higher As Tumbling Crude Oil Prices Ease Inflationary Pressures
August 03, 2026 16:59 ET
Crude Oil Nosedives After Trump Calls Off Planned Attacks On Iran
August 03, 2026 14:49 ET
Canadian Stocks Slide Amid Persisting Middle East Tensions, GDP Data Release
July 31, 2026 16:31 ET
Gold Surges As Investors Parse Fed’s Interest Rate Decision Amid Middle East Tensions
July 30, 2026 13:37 ET
Gold Slides Amid U.S.-Iran Standoff Despite Trump Canceling Planned Attacks
August 03, 2026 13:44 ET
Global Economics Weekly Update – July 27 โ July 31, 2026
August 01, 2026 02:10 ET
Major central banks, led by the U.S. Federal Reserve, and preliminary estimates of second quarter economic growth dominated the economics news flow this week. In the U.S., the Federal Reserve announced its latest policy decision and early estimates of second quarter growth and monthly inflation data were also released. In Europe, the interest rate decision from the Bank of England was in focus. Similarly, the Bank of Japan was in the limelight in Asia for its policy announcement.
View More Videos
RELATED NEWS
Bayer Consolidates U.S. Glyphosate Business Into Ruveon
Bayer Receives FDA Approval For AMBELVIST For Contrast-Enhanced MRI
Bayer’s MRI Contrast Agent Ambelvist Wins FDA Approval
Bayer Wins FDA Priority Review For Kerendia In Chronic Kidney Disease With Type 1 Diabetes
Bayer Granted Priority Review For Asundexian In Secondary Stroke Prevention
Latest Updates on COVID-19
Most Emailed
Xerox Stock Up 26% On Q2 Turnaround, Raised FY26 Outlook
July 30, 2026 08:42 ET
Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook
July 30, 2026 02:02 ET
LG Energy Solution Q2 Operating Income Falls
July 30, 2026 01:06 ET
Gildan Activewear To Sell HanesBrands Australia For A$700 Mln; Lifts Annual Adj. Income Outlook
July 30, 2026 08:31 ET
Intercontinental Exchange To Acquire MarketAxess For $167/shr
July 30, 2026 08:11 ET
Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET
Stride Names Robert Knowling CEO To Succeed James Rhyu, Prelim. Profit Climbs; Shares Down
July 30, 2026 10:05 ET
Anthropic’s AI Training Method Under Scrutiny
July 31, 2026 18:02 ET
Amazon’s Zoox Gets Approval For Paid Robotaxi Service In The U.S.
July 30, 2026 17:28 ET
LondonMetric, SREIT To Acquire Picton Property In ยฃ404 Mln Deal
July 31, 2026 08:00 ET
Franklin Resources Announces Name Change
July 31, 2026 09:52 ET
NatWest Q2 Results Climb, Lifts FY26 Income View; Plans Buybacks
July 31, 2026 02:53 ET
Sumitomo Mitsui Trust Group Q1 Net Income Rises
July 30, 2026 07:49 ET
Renault Posts H1 Net Profit As Revenue Improves, Expenses Drop
July 30, 2026 00:44 ET
GKE Corporation Ltd Reveals Retreat In Full Year Income
July 30, 2026 07:50 ET
Samsung Q2 Operating Income Surges On AI Demand; Sees Strong Demand In H2
July 30, 2026 00:54 ET
Lincoln Electric Holdings Inc. Announces Climb In Q2 Profit
July 30, 2026 07:51 ET
Shimizu Corporation Reveals Increase In Q1 Income
July 30, 2026 00:57 ET
Unibail-Rodamco-Westfield H1 Net Rental Income Declines, Announces FY26 Outlook
July 30, 2026 07:57 ET
CTS CO Ltd Q1 Profit Advances
July 30, 2026 01:01 ET
Bombardier Q2 Profit Edges Lower, But Revenue Climbs 6%
July 30, 2026 07:58 ET
Tsugami Corp Q1 Income Climbs
July 30, 2026 01:05 ET
Hutchmed China Ltd. Reveals Fall In H1 Income
July 30, 2026 07:58 ET
LG Energy Solution Q2 Operating Income Falls
July 30, 2026 01:06 ET
Editors Pick
Tyson Foods Q3 Profit Surges
August 03, 2026 09:41 ET
Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down
July 31, 2026 08:06 ET
Xerox Stock Up 26% On Q2 Turnaround, Raised FY26 Outlook
July 30, 2026 08:42 ET
GE HealthCare Stock Up 13% On Strong Q2 Profit & Orders, Positive Outlook
July 29, 2026 07:20 ET
Copyright ยฉ 2026 RTTNews. All rights reserved.By using this site, you agree to the
Terms of Service.
About Us |
Contact Us
Original source: us